首页 | 本学科首页   官方微博 | 高级检索  
     

Iressa抑制高转移性人肝癌LCI-D20原位移植瘤的血管形成
引用本文:陈方国,王杰军,薛琼,于观贞,侯亮,郭子姮. Iressa抑制高转移性人肝癌LCI-D20原位移植瘤的血管形成[J]. 中国肿瘤, 2006, 15(10): 691-694
作者姓名:陈方国  王杰军  薛琼  于观贞  侯亮  郭子姮
作者单位:1. 第二军医大学附属长征医院,上海,200070
2. 复旦大学附属中山医院肝癌研究所,上海,200032
摘    要:[目的]探讨Iressa对人高转移肝癌模型LCI-D20血管形成的抑制作用。[方法]12只原位移植LCI-D20肿瘤裸鼠分为采用空白对照组(A组)及Iressa治疗组(B组),用药28d后处死裸鼠.测量肿瘤质量,检测肿瘤组织微血管密度(MVD)。[结果]对照组肿瘤负衙平均为2.01/g,MVD平均为39.57个/HP;治疗组平均肿瘤负荷及平均MVD为1.18g、14.10个/HP,与对照组比较差异有显著性(P〈0.05)。[结论]Iressa有抑制肝癌血管形成及肿瘤生长的活性。

关 键 词:肝肿瘤  血管形成  血管形成抑制剂
文章编号:1004-0242(2006)10-0691-04
收稿时间:2006-03-16
修稿时间:2006-03-162006-04-21

Inhibitive Effect of Iressa on Angiogenesis in LCI-D20 Orthotopically Implanted High Metastatic Human Hepatocellular Carcinoma Model
CHEN Fang-guo, WANG Jie-jun, XUE Qion,et al.. Inhibitive Effect of Iressa on Angiogenesis in LCI-D20 Orthotopically Implanted High Metastatic Human Hepatocellular Carcinoma Model[J]. CHINA CANCER, 2006, 15(10): 691-694
Authors:CHEN Fang-guo   WANG Jie-jun   XUE Qion  et al.
Affiliation:1.Changzheng Hospital of the Second Military Medical University, Shanghai 200070, China; 2.Affiliated Zhongshan Hospital, Liver Cancer Institute of Fudan University, Shanghai 200032, China
Abstract:[Purpose] To explore the inhibitive effect of Iressa on angiogenesis of highly metastatic human hepatocellular carcinoma model of LCI-D20.[Methods] Twelve nude mouse via orthotopic implantation of LCI-D20 were randomized into two groups:control group(A group)and Iressa group(B group).Tumor mass and microvessel density(MVD)were measured at the 28th-day of treatment.[Results] The mean tumor mass were 2.01g and 1.18g in A and B group respectively.The mean MVD were 39.57/HP and 14.10/HP in A and B group respectively.There was significant difference between two groups(P<0.05).[Conclusion] Iressa inhibits the growth of tumor and angiogenesis of hepatocellular carcinoma.
Keywords:Iressa
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号